Genmab — September 2018

[E_L]

On the CMD discussion yesterday, I think we can expect something similar to 2016? Again, it is 3 hours, in 2016 we had 2 hours of Clinical update, and pre-clinical pipeline and technologies and a small slot on pre-clinical projects by Paul Parren

[E_L]

then we had half an hour of Building the business for the future and commercial expertise, followed by 1/2 hour Q&A

[E_L]

A lot of it will be known to us, but possibly not to other investors. It should be much more detailed as the Morgan Stanly presentation I would think

[gentogen]

Lidt om Janssens fabriksplaner ("The expanded facility is expected to produce 72 batches of monoclonal antibody product a year.") https://www.pharmaceutical-technology.com/projects/janssen-biologics-manufacturing-facility-expansion-ringaskiddy-ireland/

[gentogen]

En art ketchupeffekt....

[StockBull]

Mener ikke der har været problermer med at producere nok Darzalex, derimod problemer med sygehuskapacitet

[peter12]

Hvor bliver den produceret i dag ? Der var problem i Puerto Rico sidste år https://eu.usatoday.com/story/money/2017/09/22/hurricane-maria-pharmaceutical-industry-puerto-rico/692752001/

[Nickstar]

JV/ Tak for svar

[Legolas23]

Mon ikke når Darzalex er godkendt i Maia studiet, så får man brug for en del mere.

[Solsen]

Men patientgrundlaget fordobles med firstline.

[Solsen]

[Legolas23]

Nemlig!

[jkj]

Jeg er begyndt at tvivle om vi får besked omkring MAIA inden udgangen af september, håber a
t der er lidt afklarende informationer på CMD.

[Sukkeralf]

Jeg tvivler på vi får det inden udgangen af oktober

[AaBforever]

Rachel...MAIA headlines soon..

[bikube]

Tak Aab - Jeg håber hendes soon er sooner, end Jans, som jeg synes kan trække ud.

[gentogen]

sooner or later

[gentogen]

Manuel ville vel sige "eventually"...

[Helge_LarsenPI-redaktør]

Analyse på cannabismarkedet. http://www.proinvestor.com/debat/76190

[Sukkeralf]

I learned it from a book.........